dual PPAR alpha/gamma agonists (Biovitrum)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug Namedual PPAR alpha/gamma agonists (Biovitrum)
Drug Alias NameBVT-142 analogs (Biovitrum)BVT-13BVT-142
ClassificationSmall molecules
Mechanisms of ActionPeroxisome proliferator-activated receptor γ agonistsInsulin sensitizersPeroxisome proliferator-activated receptor α agonists
TargetsPeroxisome proliferator-activated receptor γPeroxisome proliferator-activated receptor α
Therapy Area/IndicationsDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySweden
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSwedish Orphan Biovitrum Ab (Publ)
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSwedish Orphan Biovitrum Ab (Publ)
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus, Type 2

Other Information

ATC CodeN/A
Related LinksN/A